ANIX - ITUS （Anixa Biosciences Inc.）ANIXのニュース
Anixa Biosciences PT Raised to $12 at H.C. Wainwright 2023/03/23 10:37:04 Investing.com
https://www.investing.com/news/pro/anixa-biosciences-pt-raised-to-12-at-hc-wainwright-432SI-3037559
Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank 2023/03/13 12:30:00 PR Newswire
SAN JOSE, Calif., March 13, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today reassured its shareholders and the investment community that it does not have any accounts at recently collapsed…
Chardan Capital Markets Starts Anixa Biosciences at Buy 2022/12/23 10:52:01 Investing.com
https://www.investing.com/news/pro/chardan-capital-markets-starts-anixa-biosciences-at-buy-432SI-2969669
Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022/10/10 12:30:00 PR Newswire
SAN JOSE, Calif., Oct. 10, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining its ovarian cancer CAR-T therapy trial at the Society for…
Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More 2022/09/24 13:30:00 Marketing Sentinel
In last trading session, Anixa Biosciences Inc. (NASDAQ:ANIX) saw 0.41 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price level of $5.13 trading at -$0.97 or -15.90% at ring of the bell on the day assigns it a market valuation of $123.43M. That closing price of ANIX’s stock is … Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More Read More »
Chardan Capital Markets Starts Anixa Biosciences at Buy 2022/12/23 10:52:01 Investing.com
https://www.investing.com/news/pro/chardan-capital-markets-starts-anixa-biosciences-at-buy-432SI-2969669
Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022/10/10 12:30:00 PR Newswire
SAN JOSE, Calif., Oct. 10, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining its ovarian cancer CAR-T therapy trial at the Society for…
Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More 2022/09/24 13:30:00 Marketing Sentinel
In last trading session, Anixa Biosciences Inc. (NASDAQ:ANIX) saw 0.41 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price level of $5.13 trading at -$0.97 or -15.90% at ring of the bell on the day assigns it a market valuation of $123.43M. That closing price of ANIX’s stock is … Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More Read More »
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday 2022/09/19 05:53:09 Benzinga
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA ) shares jumped 53% to close at $0.58 on Friday. Applied Optoelectronics, Inc. (NASDAQ: AAOI ) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million. iBio, Inc. (NYSE: IBIO ) gained 49.8% to close at $0.46. Armata Pharmaceuticals, Inc. (NYSE: ARMP ) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share. Axcella Health Inc. (NASDAQ: AXLA ) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share. Anixa Biosciences, Inc. (NASDAQ: ANIX ) gained 27.5% to close at $5.71. Lannett Company, Inc. (NYSE: LCI ) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago Integrated Media Technology Limited (NASDAQ: IMTE ) climbed 21.5% to close at $1.75. Decisionpoint Systems, Inc. (NASDAQ: DPSI ) rose 20.8% to close at $5.93.
Is Anixa Biosciences Inc. (NASDAQ: ANIX) Still A Buy After A 37.92% Weekly Jump? 2022/09/17 20:00:00 Marketing Sentinel
During the last session, Anixa Biosciences Inc. (NASDAQ:ANIX)’s traded shares were 0.57 million, with the beta value of the company hitting 1.28. At the end of the trading day, the stock’s price was $5.71, reflecting an intraday gain of 27.46% or $1.23. The 52-week high for the ANIX share is $5.55, that puts it up … Is Anixa Biosciences Inc. (NASDAQ: ANIX) Still A Buy After A 37.92% Weekly Jump? Read More »
Chardan Capital Markets Starts Anixa Biosciences at Buy 2022/12/23 10:52:01 Investing.com
https://www.investing.com/news/pro/chardan-capital-markets-starts-anixa-biosciences-at-buy-432SI-2969669
Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022/10/10 12:30:00 PR Newswire
SAN JOSE, Calif., Oct. 10, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining its ovarian cancer CAR-T therapy trial at the Society for…
Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More 2022/09/24 13:30:00 Marketing Sentinel
In last trading session, Anixa Biosciences Inc. (NASDAQ:ANIX) saw 0.41 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price level of $5.13 trading at -$0.97 or -15.90% at ring of the bell on the day assigns it a market valuation of $123.43M. That closing price of ANIX’s stock is … Anixa Biosciences Inc. (NASDAQ:ANIX) Projected To Shrink By -114.42% Or More Read More »
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday 2022/09/19 05:53:09 Benzinga
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA ) shares jumped 53% to close at $0.58 on Friday. Applied Optoelectronics, Inc. (NASDAQ: AAOI ) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million. iBio, Inc. (NYSE: IBIO ) gained 49.8% to close at $0.46. Armata Pharmaceuticals, Inc. (NYSE: ARMP ) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share. Axcella Health Inc. (NASDAQ: AXLA ) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share. Anixa Biosciences, Inc. (NASDAQ: ANIX ) gained 27.5% to close at $5.71. Lannett Company, Inc. (NYSE: LCI ) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago Integrated Media Technology Limited (NASDAQ: IMTE ) climbed 21.5% to close at $1.75. Decisionpoint Systems, Inc. (NASDAQ: DPSI ) rose 20.8% to close at $5.93.
Is Anixa Biosciences Inc. (NASDAQ: ANIX) Still A Buy After A 37.92% Weekly Jump? 2022/09/17 20:00:00 Marketing Sentinel
During the last session, Anixa Biosciences Inc. (NASDAQ:ANIX)’s traded shares were 0.57 million, with the beta value of the company hitting 1.28. At the end of the trading day, the stock’s price was $5.71, reflecting an intraday gain of 27.46% or $1.23. The 52-week high for the ANIX share is $5.55, that puts it up … Is Anixa Biosciences Inc. (NASDAQ: ANIX) Still A Buy After A 37.92% Weekly Jump? Read More »